Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PainChek Ltd ( (AU:PCK) ) has issued an announcement.
PainChek Ltd announced the cessation of 5.8 million securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development may impact the company’s capital structure and could have implications for its market positioning and stakeholder interests.
More about PainChek Ltd
PainChek Ltd operates within the healthcare technology industry, primarily focusing on developing innovative pain assessment solutions. The company is known for its digital pain assessment tool, which uses facial recognition technology to assess pain levels in individuals who may not be able to communicate effectively.
Average Trading Volume: 1,859,049
Technical Sentiment Signal: Buy
Current Market Cap: A$66.31M
See more data about PCK stock on TipRanks’ Stock Analysis page.